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Abstract
Aim: Predictors of 50 day in-hospital mortality in decompensated cirrhosis patients with 
spontaneous bacterial peritonitis (SBP).
Methods: 218 SBP patients admitted to intensive care units in a tertiary care hospital 
were retrospectively analyzed. Student t test, multivariate logistic regression, Cox pro-
portional hazard ratio, receiver operating characteristics curves and Kaplan-Meier sur-
vival analysis were utilized for statistical analysis. Predictive powers of the statistical 
significant variables were compared using the area under receiver operating characteris-
tics curve (AUC). p values <0.05 were considered statistical significant.
Results: SBP related in-hospital mortality rate was 43%. Multivariate regression analysis 
showed acute kidney injury, hepatic encephalopathy, positive ascitic culture, leucocyte 
count, bilirubin, serum glutamic oxaloacetic transaminase (SGOT), Child Pugh score, 
and Model for End stage Liver Disease Sodium (MELD-Na) were significantly associ-
ated with 50 day in-hospital mortality. The prognostic accuracy for acute kidney injury, 
MELD-Na and septic shock was 77, 74 and 71% respectively.
Conclusion: Acute kidney injury, MELD-Na and septic shock were predictors of 50 day 
in-hospital mortality in decompensated cirrhotic patients with SBP.
Keywords: spontaneous bacterial peritonitis, cirrhosis, acute kidney injury, model for 
end stage liver disease sodium
© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
1. Introduction
SBP is defined as an ascitic fluid infection without an evident intra-abdominal surgically-
treatable source [1]. SBP is a major complication of decompensated cirrhosis with ascites 
[2]. The diagnosis of SBP is established based on diagnostic paracentesis with an elevated 
ascitic fluid absolute polymorphonuclear leucocyte (PMN) count (≥250 cells/mm3) and/
or a positive ascitic fluid bacterial culture. The most common pathogens involved are 
Gram-negative bacteria (60%), usually Escherichia coli or Klebsiella pneumonia [3]. In about 
25% of the cases, Gram-positive bacteria are involved, mainly Streptococcus species and 
Enterococci [3]. The prevalence of SBP is up to 30% in hospitalized cirrhotic patients with 
ascites [4]. Despite intensive management, the in-hospital mortality remains between 20 
and 40% [5]. MELD scores have clinical utility in terms of predictive ability in SBP patients 
[6, 7]. Acute kidney injury (AKI) and septic shock are fairly common in patients with decom-
pensated cirrhosis with ascites [8, 9]. Hence our study aimed to have a collective approach 
to determine common prognostic factors predicting SBP related in-hospital mortality. We 
also compared the predictive powers of AKI, MELD-Na and septic shock to predict 50 day 
in-hospital mortality.
2. Materials and methods
2.1. Patients
Retrospective analysis and review of 218 adult patients admitted to hepatology ICU with a 
diagnosis of SBP was done. The study was approved by the Institutional review Board and 
was conducted with the provisions of Declaration of Helsinki [10].
The diagnosis of cirrhosis was based on clinical, laboratory and imaging findings. SBP was 
diagnosed by diagnostic paracentesis in the presence of PMN ≥250 cells/mm3 in the peritoneal 
fluid with positive culture report and the absence of the features suggestive of secondary 
bacterial peritonitis [11].
Data from patient’s medical records were collected and tabulated. It comprises of demograph-
ics, etiology of liver disease, severity of liver disease, laboratory parameters, co-existing medi-
cal conditions (diabetes mellitus, hepatocellular carcinoma), previous medication use, organ 
failure, ascitic fluid analysis results, duration of ICU stay, and patient outcome. In culture-
positive cases growth of the organisms and antibiotic sensitivity were recorded.
MELD-Na score was based on laboratory parameters (bilirubin, creatinine levels and INR) 
collected at admission and determined by using the Internet site MELD calculator [12]. 
Diagnostic ascitic tapping was done upon admission to ICU in all patients with ascites except 
in those with severe coagulopathy. Ascitic fluid was sent for differential cell count and cul-
ture. Blood sample was also sent for culture at admission in all patients. Antibiotics adminis-
tered in patients based on previous antibiotic exposure and based on culture and sensitivity. 
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No patient underwent fluid restriction or hypertonic saline for management of dilution 
hyponatremia.
AKI was defined by AKIN (acute kidney injury network) criteria [8]. AKI was managed by 
intravenous vasopressors (terlipressin) and intravenous albumin infusions. The dose was 
titrated as-per response and tolerance. Intravenous albumin was used in all patients, with a 
minimal daily dose of 20 g and increased to up to 60 g/d [13], titrated by clinical monitoring 
and hourly urine output. We did not stratify renal dysfunction into hepatorenal syndrome 
(HRS) and non-hepatorenal syndrome. Renal replacement therapy (RRT) was used at the 
bedside to correct fluid overload, ascites, and electrolyte dysfunction. We did not consider 
advanced liver disease as a contraindication to RRT in our patient cohort.
We defined septic shock according to the American college of chest physicians/society of criti-
cal care medicine consensus conference [14].
2.2. Exclusion criteria
Patients with cirrhosis and ascites fluid PMN <250 cells/mm3. Patients admitted from the com-
munity with SBP. Patients presented with ascites unrelated to cirrhosis. Patients with second-
ary peritonitis, variceal hemorrhage, advanced malignancy and HIV.
2.3. Statistical analysis
All statistical analyses were conducted using Stata version 14 for windows. The continuous 
clinical and biochemical variables and prognostic scores were expressed as mean ± standard 
deviation. All the variables were assumed to be normally distributed with equal variance. 
The means were compared using student’s t test. Categorical variables were expressed as 
proportions and compared with logistics regression. All significant variables were analyzed 
using multivariate logistics regression. Cox proportional hazard model was used to analyze 
the hazard ratio of the predictors adjusted by age and gender. Receiver operating characteris-
tics (ROC) curves were plotted for prognostic variables (MELD-Na, AKI and) to measure the 
predictive accuracy. The best cut-off point for MELD-Na was created using the ROC analysis 
to determine 50 day in-hospital mortality risk. The sensitivity, specificity, positive predic-
tive values (PPV), negative predictive values (NPV), positive and negative likelihood ratio 
were calculated for each predictor variable so that patients could be correctly classified for 
each prognostic model. For all analyses, p value < 0.05 was considered statistically significant. 
STROBE checklist for retrospective analysis was performed.
3. Results
A total of 218 patients with decompensated cirrhosis with ascites and SBP were included in 
the study. Patients that were diagnosed with SBP for the first time were 97% (n = 211) with 
only 0.03% (n = 7) had more than one episode previously. The 50 day in-hospital mortality 
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Variables Overall (n = 218) Survivors (n = 124) Deaths (n = 94) P-value
Demographic data
Age (yrs) mean ± SD 49.90 ± 12.52 49.86 ± 13.37 49.96 ± 11.37 0.950
Male (%) 177 (81.19%) 99 (79.84%) 78 (82.98%) 0.557
Etiology of cirrhosis (%)
Ethanol 100 (45.87%) 48 (38.71%) 52 (55.32%) 0.689
Crypto/NAFLD 63 (28.90%) 38 (30.65%) 25 (26.60%) 0.104
HCV 23 (10.55%) 16 (12.905) 7 (7.45%) 0.068
Clinical data (%)
Hepatocellular 
carcinoma
17 (7.80%) 9 (7.26%) 8 (8.51%) 0.733
Diabetes 47 (21.56%) 27 (21.77%) 20 (21.28%) 0.929
Acute kidney injury 99 (45.41%) 35 (28.23%) 64 (68.09%) <0.001
Respiratory failure 10 (4.59%) 6 (4.84%) 4 (4.26%) 0.978
Hepatic 
encephalopathy
109 (50.0%) 50 (40.32%) 59 (62.77%) 0.001
Septic shock 28 (12.84%) 4 (3.23%) 24 (25.53%) <0.001
Positive culture 48 (22.02%) 21 (16.94%) 27 (28.72%) 0.038
Laboratory data* (mean ± SD)
Ascitic neutrophil 
count (cells/mm3)
3346.07 ± 4700.60 3899.28 ± 5003.75 2616.30 ± 4182.81 0.040
Hemoglobin (g/dl) 9.42 ± 1.88 9.58 ± 1.77 9.21 ± 2.01 0.154
Platelet count 
(mmol/L)
128.24 ± 102.11 138.43 ± 111.25 115.03 ± 87.69 0.095
Leucocyte count 
(103/μL)
13.30 ± 9.35 11.86 ± 8.65 15.17 ± 9.92 0.009
Sodium (mEq/L) 132.14 ± 7.69 132.50 ± 6.54 131.67 ± 9.01 0.454
Bilirubin (mg/dL) 8.17 ± 8.81 5.85 ± 6.27 11.24 ± 10.61 <0.001
Albumin (g/dL) 2.32 ± 0.50 2.35 ± −0.48 2.28 ± 0.52 0.250
INR 2.31 ± 1.11 2.09 ± 1.08 2.59 ± 1.08 0.001
AST (U/L) 59.66 ± 109.81 79.23 ± 98.71 171.3 ± 321.94 0.003
ALT (U/L) 59.66 ± 109.81 46.49 ± 72.93 77.04 ± 143.41 0.041
Urea (mg/dL) 70.31 ± 52.42 62.24 ± 48.23 80.94 ± 55.98 0.008
Creatinine (mg/dL) 1.67 ± 1.29 1.58 ± 1.39 1.80 ± 1.15 0.217
Scores (mean ± SD)
CTP (B/C) 10.72 ± 1.82 10.50 ± 1.95 11.02 ± 1.60 0.034
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rate was 43.11% (n = 94). Median survival duration for those who died was 9 days. In univari-
ate analysis AKI, hepatic encephalopathy, total leucocyte count, serum bilirubin, INR, SGOT, 
and MELD-Na are significantly associated with in hospital mortality in patients with SBP 
(Table 1).
The baseline characteristics of the demographics, etiology, clinical and laboratory data 
shown in Table 1. Mean age was 49.90 ± 12.52 years and the male was predominant (83%). 
Most common etiology of liver cirrhosis was ethanol induced (45.87%) followed by crypto/
NAFLD (28.9%). Liver cirrhosis due to HCV infection constitute only 11% in our study. 
Total 50.0% patients (n = 109) had hepatic encephalopathy with 62.77% deaths (n = 59, 
p = 0.001). Overall 45.11% subjects (n = 99) had AKI who were hospitalized, out of which 
68.09% (n = 64, p ≤ 0.001) died. Compared with survivors, the non-survivors had a higher 
proportion of septic shock (25.53 vs. 3.23%), p < 0.001. Mean leucocyte count, bilirubin, 
INR, AST were significantly higher in the persons who died in comparing to the survivors. 
Mean MELD-Na score was higher among the non-survivors compared with the survivors 
(30.59 ± 6.62 vs. 25.21 ± 7.44) (p < 0.001). It is surprising to notice that CTP (B/C) score 
was not different among the survivors and non-survivors. The mean CTP scores were high 
(10.72 ± 1.82).
On multivariate regression analysis, AKI (p = 0.001), septic shock (p = 0.029), MELD-Na 
(p < 0.001) were found to be independent predictors of 50 day in-hospital mortality in patients 
with SBP (Table 2). Cox proportional hazard model showed the hazard ratio of AKI was 
2.16 (95% CI = 1.36–3.42), septic shock (HR 1.73, 95% CI = 1.05–2.83) and MELD-Na (HR 1.1, 
95% CI = 1.02–1.21). ROC curve for AKI, septic shock and MELD-Na had better prognostic 
Variables Overall (n = 218) Survivors (n = 124) Deaths (n = 94) P-value
MELD 24.79 ± 8.28 22.20 ± 7.59 28.20 ± 7.94 <0.001
MELD-Na 27.53 ± 7.57 25.21 ± 7.44 30.59 ± 6.62 <0.001
*Results obtained on the day of diagnosis of SBP.
Table 1. Baseline characteristics of the hospitalized patients with spontaneous bacterial peritonitis in decompensated 
cirrhosis.
Variables Hazard ratio*
(95% CI)
P value
AKI 2.16 (1.36–3.42) 0.001
Septic shock 1.73 (1.05–2.83) 0.029
MELD-Na 1.06 (1.02–1.09) <0.001
*Hazard ratio adjusted for age and gender.
AKI, acute kidney injury; MELD-Na, model for end-stage liver disease sodium.
Table 2. Cox proportional regression analysis of risk factors for SBP related in-hospital related mortality.
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accuracy for 50 day in-hospital mortality in patients with SBP (Figure 1). AKI had highest 
Area Under Curve (AUC) 0.77, 95% confidence interval (95% CI = 0.71–0.83), followed by 
MELD-Na (AUC 0.74, 95% CI = 0.69–0.79), septic shock (AUC 0.71, 95% CI = 0.65–0.77). Table 3 
reported the sensitivity, specificity, PPV, NPV, positive likelihood ratio (+LR) and nega-
tive likelihood ratio (−LR) for these predictors. The cut off for MELD-Na derived from 
the ROC with the best ability to predict 50 day in-hospital mortality in decompensated 
cirrhotic patient with SBP was 28, with sensitivity 92.9%, specificity 60.3%, and NPV of 
97.9%. The Kaplan-Meier survival analysis was plotted for the 50 day survival in SBP 
patients along with individual prognostic variables like AKI, MELD-Na, and septic shock 
(Figure 2).
Predictors Sensitivity Specificity PPV NPV +LR −LR
AKI 64.6 74.8 68.1 71.8 2.56 0.47
Septic shock 85.7 63.2 25.5 96.8 2.33 0.23
MELD-Na(28)1 92.9 60.3 24.5 97.9 2.34 0.12
1Cut off score for MELD-Na, PPV: positive predictive value, NPV: negative predictive value, +LR: positive likelihood 
ratio, −LR: negative likelihood ratio, AKI: acute kidney injury, MELD-Na: model for end stage liver disease sodium.
Table 3. Diagnostic accuracy of prognostic variables to predict SBP related in-hospital mortality.
Figure 1. Receiver operator characteristic (ROC) curve for AKI, septic shock and MELD-Na had better prognostic 
accuracy for 50 day in-hospital mortality in patients with SBP.
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4. Discussion
The prevalence of SBP in outpatients has been reported to be 1.5–3.5% [15]. The prevalence 
among in-patients is around 10% [16]. Half of the episodes of SBP are nosocomial related. In 
our retrospective observational study 43% (n = 93) of the decompensated cirrhotic patients 
with SBP died within 50 day of hospital admission. Our study considered a variety of prog-
nostic factors that can be used to predict mortality in hospitalized patient with SBP. Our find-
ings support previous study results that variables like hepatic encephalopathy, total leucocyte 
count, serum bilirubin, SGOT, INR, Child Pugh scores are significantly associated with mor-
tality [5, 6]. The MELD score was found to be an independent predictor of death in cirrhotic 
patients [7] including those waiting for liver transplantation. MELD-Na is a better prognostic 
model compared with MELD model [17] for predictive accuracy of mortality in liver cirrhosis. 
Serum creatinine level measurement for renal dysfunction in decompensated liver cirrhosis 
is erroneous. It can be due to decrease in creatinine production in liver and associated muscle 
wasting due to malnutrition [18]. We found that AKI, MELD-Na and septic shock are sig-
nificant in terms of predicting mortality. We overlooked other predictable variables like total 
leucocyte count, serum bilirubin, INR to avoid confusion and complexity as those were the 
components in our predictive model like MELD-Na and septic shock.
Figure 2. Kaplan-Meier survival analysis was plotted for the 50 day survival in SBP patients along with individual 
prognostic variables like AKI, MELD-Na, and septic shock.
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Our study demonstrated that AKI has the single best predictive ability (AUC = 0.77) followed 
by MELD-Na (AUC = 0.74) and septic shock (AUC = 0.71). We set a cut-off value for MELD-Na 
to be 28. It has sensitivity 92.9% and NPV of 97.9%. AKI has the highest hazards of mortal-
ity (HR 2.16, 95% CI 1.36–3.42) followed by septic shock (HR 1.73, 95% CI 1.05–2.83) and 
MELD-Na (HR 1.06, 95% 1.02–1.09). We plotted graph of Kaplan-Meier survival analysis. The 
graph illustrated AKI, MELD-Na, and septic shock as predictors for the 50 day in-hospital 
mortality in decompensated patients with SBP. We hope that these prognostic variables can 
help in the further improvement of the quality of care of hospitalized SBP patients. The cut-off 
value 28 for MELD-Na can be utilized to stratify patients diagnosed with SBP into high risk 
category upon hospital admission.
Diagnosis of SBP is based on the demonstration of an absolute number of polymorphonuclear 
cells in ascitic fluid equal to or greater than 250/mm3 with culture positivity. There is a contro-
versy regarding antibiotic therapy in culture positivity with normal ascitic fluid PMN count 
(bacteriascites). Runyon et al. recommend antibiotic treatment only if the patient shows signs 
of infection [2]. The first-line of choice antibiotics for treatment of SBP include third genera-
tion cephalosporins, amoxicillin-clavulanic acid, ciprofloxacin, and ofloxacin [19]. There is 
increasing evidence of antibiotic resistance [20].
In our study ascitic fluid culture is positive in 40% of all cases. The most common growth 
include Gram-negative bacteria (GNB), mostly Escherichia coli and Gram-positive cocci 
(mainly streptococcus species and enterococci) [3]. The epidemiology of bacterial infections 
differs between community-acquired (in which GNB infections predominate) and nosocomial 
infections (in which Gram-positive infections predominate) [3]. The infections resistant to 
first lines of antibiotics are usually caused by Enterococcus faecium and extended-spectrum 
β-lactamase (ESBL) organism like Enterobacteriaceae [21]. There are compelling evidence that 
nosocomial SBP should be treated with carbapenems or with tigecycline [22].
We included only nosocomial SBP patients in our study because most of the ICU admissions 
includes referred patients from other hospitals, with a variable but inconsistent antibiotic expo-
sure. Only a minority of our patients are admitted directly from the community, and usually to 
the wards and not to the ICU. Hospital-acquired infections due to a higher incidence of multi-
drug resistance (third-generation cephalosporins) were an independent predictor of death [23]. 
These results are in keeping with recent data showing higher rates of drug resistance in patients 
with nosocomial SBP and increased rates of and death in patients with multidrug resistance [24].
Dr. Garcia-Tsao recently reviewed 18 studies, and reported that the most common predic-
tors of death were renal dysfunction, lack of SBP resolution, immunosuppressive factors, and 
hospital-acquired SBP [24]. It identified renal dysfunction and levels of blood urea nitrogen 
and creatinine as the most important variables. The mortality rate among patients with renal 
dysfunction was 67%, compared with only 11% of patients who maintained normal renal 
function. Renal dysfunction was defined somewhat variably in the studies, but most defined 
it as a creatinine level greater than 1.5 mg/dL.
Our study has certain strengths and limitations. The results clearly show that AKI has greater 
predictive ability than septic shock and MELD-Na as far as 50 day in-hospital mortality in SBP 
patient is concerned. Our study did not account for the stages of ascites. We did not stratify 
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our patients according to different stages of AKI as per AKIN criteria. We did not take HRS 
into account in our study. The standard first line antibiotics were not used in the treatment of 
SBP. The choice of antibiotics coverage based of culture sensitivity and previous exposure. We 
did not thoroughly evaluate the antibiotic resistance in SBP patients who are culture positive 
at the baseline. We included only nosocomial acquired SBP. Most of our patients presented 
with advanced decompensated liver cirrhosis at the time of SBP diagnosis as it is a tertiary care 
center. The advanced liver cirrhosis was assessed by lower serum albumin, high serum biliru-
bin and INR values. As an observational study we were unable to assess the impact of volume 
expansion and SBP specific therapy on patient outcome. Our study is a single center study, 
these findings needed to be supplemented by multicenter prospective studies.
Our study findings can guide in advanced liver cirrhosis patients that would benefit them 
from intensive management where liver transplant is not feasible.
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